Local production of fatty acid-binding protein 4 in epicardial/perivascular fat and macrophages is linked to coronary atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 825-834

  Furuhashi, Masato ^a   Fuseya, Takahiro ^a   Murata, Masaki ^a   Hoshina, Kyoko ^a   Ishimura, Shutaro ^a,c   Mita, Tomohiro ^a   Watanabe, Yuki ^a   Omori, Akina ^a   Matsumoto, Megumi ^a   Sugaya, Takeshi ^d,e   Oikawa, Tsuyoshi ^e   Nishida, Junichi ^a   Kokubu, Nobuaki ^a   Tanaka, Marenao ^a   Moniwa, Norihito ^a   Yoshida, Hideaki ^a   Sawada, Norimasa ^a   Shimamoto, Kazuaki ^b   Miura, Tetsuji ^a,c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c Obihiro Kosei Hospital   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Dept of Epidemiol and Biostatist   (Japan)

Author keywords

adipokine; atherosclerosis; coronary stenosis; fatty acid binding protein 4; macrophage

Indexed keywords

FATTY ACID BINDING PROTEIN 4; RECOMBINANT PROTEIN; FABP4 PROTEIN, HUMAN; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY SINUS; CORONARY VEIN; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; EPICARDIAL FAT; GENE EXPRESSION; GENSINI SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERIVASCULAR FAT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; VASCULAR SMOOTH MUSCLE CELL; 3T3-L1 CELL LINE; ANIMAL; CELL MOTION; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PARACRINE SIGNALING; PATHOLOGY; RAW 264.7 CELL LINE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; FATTY ACID-BINDING PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MALE; MICE; MULTIVARIATE ANALYSIS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PARACRINE COMMUNICATION; PLAQUE, ATHEROSCLEROTIC; RAW 264.7 CELLS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84961572849     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307225     Document Type: Article

References (48)

1. Furuhashi M, Hotamisligil GS, Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008 7 489 503. doi: 10.1038/nrd2589
2. Furuhashi M, Ishimura S, Ota H, Miura T, Lipid chaperones and metabolic inflammation. Int J Inflam 2011 2011 642612. doi: 10.4061/2011/642612
3. Furuhashi M, Saitoh S, Shimamoto K, Miura T, Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol 2014 8 suppl 3 23 33. doi: 10.4137/CMC.S17067
4. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM, Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996 274 1377 1379
5. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF, Lack of macrophage fatty-Acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001 7 699 705. doi: 10.1038/89076
6. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS, Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008 118 2640 2650. doi: 10.1172/JCI34750
7. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS, Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 2004 110 1492 1498. doi: 10.1161/01.CIR.0000141735.13202.B6
8. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS, Treatment of diabetes and atherosclerosis by inhibiting fatty-Acid-binding protein aP2. Nature 2007 447 959 965. doi: 10.1038/nature05844
9. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS, Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006 52 405 413. doi: 10.1373/clinchem.2005.062463
10. Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, White A, Inouye K, Rickey LM, Ercal BC, Furuhashi M, Tuncman G, Hotamisligil GS, Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 2013 17 768 778. doi: 10.1016/j.cmet.2013.04.012
11. Mita T, Furuhashi M, Hiramitsu S, FABP4 is secreted from adipocytes by adenyl cyclase-PKA-And guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity (Silver Spring) 2015 23 359 367. doi: 10.1002/oby.20954
12. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH, Ehrhart-Bornstein M, Bornstein SR, Morano I, Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009 105 326 334. doi: 10.1161/CIRCRESAHA.109.200501
13. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS, Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007 115 1537 1543. doi: 10.1161/CIRCULATIONAHA.106.647503
14. von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H, Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 2012 32 2327 2335. doi: 10.1161/ATVBAHA.112.248609
15. Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, Fuseya T, Yamashita T, Tanaka M, Yoshida H, Shimamoto K, Miura T, Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation. Am J Hypertens 2012 25 1124 1130. doi: 10.1038/ajh.2012.88
16. Ishimura S, Furuhashi M, Watanabe Y, Hoshina K, Fuseya T, Mita T, Okazaki Y, Koyama M, Tanaka M, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Miura T, Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One 2013 8 e81318. doi: 10.1371/journal.pone.0081318
17. Furuhashi M, Ishimura S, Ota H, Hayashi M, Nishitani T, Tanaka M, Yoshida H, Shimamoto K, Hotamisligil GS, Miura T, Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS One 2011 6 e27356. doi: 10.1371/journal.pone.0027356
18. Fuseya T, Furuhashi M, Yuda S, Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population. Cardiovasc Diabetol 2014 13 126. doi: 10.1186/s12933-014-0126-7
19. Doi M, Miyoshi T, Hirohata S, Nakamura K, Usui S, Takeda K, Iwamoto M, Kusachi S, Kusano K, Ito H, Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 2011 10 44. doi: 10.1186/1475-2840-10-44
20. Agardh HE, Folkersen L, Ekstrand J, Marcus D, Swedenborg J, Hedin U, Gabrielsen A, Paulsson-Berne G, Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 2011 269 200 210. doi: 10.1111/j.1365-2796.2010.02304.x
21. Peeters W, de Kleijn DP, Vink A, van de Weg S, Schoneveld AH, Sze SK, van der Spek PJ, de Vries JP, Moll FL, Pasterkamp G, Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J 2011 32 1758 1768. doi: 10.1093/eurheartj/ehq387
22. Sacks HS, Fain JN, Human epicardial adipose tissue: a review. Am Heart J 2007 153 907 917. doi: 10.1016/j.ahj.2007.03.019
23. Itakura H, Yokoyama M, Matsuzaki M, JELIS Investigators Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb 2011 18 99 107
24. Ho E, Shimada Y, Formation of the epicardium studied with the scanning electron microscope. Dev Biol 1978 66 579 585
25. Aghamohammadzadeh R, Withers S, Lynch F, Greenstein A, Malik R, Heagerty A, Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br J Pharmacol 2012 165 670 682. doi: 10.1111/j.1476-5381.2011.01479.x
26. Ishii T, Asuwa N, Masuda S, Ishikawa Y, The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol 1998 185 4 9
27. Wisneski JA, Gertz EW, Neese RA, Mayr M, Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987 79 359 366. doi: 10.1172/JCI112820
28. Nelson RH, Prasad A, Lerman A, Miles JM, Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes 2007 56 527 530. doi: 10.2337/db06-1552
29. Marchington JM, Mattacks CA, Pond CM, Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989 94 225 232
30. Marchington JM, Pond CM, Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990 14 1013 1022
31. Vural B, Atalar F, Ciftci C, Demirkan A, Susleyici-Duman B, Gunay D, Akpinar B, Sagbas E, Ozbek U, Buyukdevrim AS, Presence of fatty-Acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovasc Pathol 2008 17 392 398. doi: 10.1016/j.carpath.2008.02.006
32. Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J, Lipid signaling in adipose tissue: Connecting inflammation & metabolism. Biochim Biophys Acta 2015 1851 503 518. doi: 10.1016/j.bbalip.2014.09.023
33. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS, The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-Activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005 280 12888 12895. doi: 10.1074/jbc.M413788200
34. Fu Y, Luo N, Lopes-Virella MF, Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res 2000 41 2017 2023
35. Shum BO, Mackay CR, Gorgun CZ, Frost MJ, Kumar RK, Hotamisligil GS, Rolph MS, The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 2006 116 2183 2192. doi: 10.1172/JCI24767
36. Grimsrud PA, Picklo MJ Sr, Griffin TJ, Bernlohr DA, Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 2007 6 624 637. doi: 10.1074/mcp.M600120-MCP200
37. Hitomi M, Odani S, Ono T, Glutathione-protein mixed disulfide decreases the affinity of rat liver fatty acid-binding protein for unsaturated fatty acid. Eur J Biochem 1990 187 713 719
38. Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ, Petersen DR, Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS One 2012 7 e38459. doi: 10.1371/journal.pone.0038459
39. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I, Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004 114 1752 1761. doi: 10.1172/JCI21625
40. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS, TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006 116 3015 3025. doi: 10.1172/JCI28898
41. Girona J, Rosales R, Plana N, Saavedra P, Masana L, Vallvé JC, FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS One 2013 8 e81914. doi: 10.1371/journal.pone.0081914
42. Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L, Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012 11 72. doi: 10.1186/1475-2840-11-72
43. Wu LE, Samocha-Bonet D, Whitworth PT, Fazakerley DJ, Turner N, Biden TJ, James DE, Cantley J, Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab 2014 3 465 473. doi: 10.1016/j.molmet.2014.02.005
44. Chow WS, Tso AW, Xu A, Yuen MM, Fong CH, Lam TH, Lo SV, Tse HF, Woo YC, Yeung CY, Cheung BM, Lam KS, Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc 2013 2 e004176. doi: 10.1161/JAHA.112.004176
45. Furuhashi M, Mita T, Moniwa N, Hoshina K, Ishimura S, Fuseya T, Watanabe Y, Yoshida H, Shimamoto K, Miura T, Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension. Hypertens Res 2015 38 252 259. doi: 10.1038/hr.2015.2
46. Karpisek M, Stejskal D, Kotolova H, Kollar P, Janoutova G, Ochmanova R, Cizek L, Horakova D, Yahia RB, Lichnovska R, Janout V, Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia. Eur J Clin Invest 2007 37 637 642. doi: 10.1111/j.1365-2362.2007.01835.x
47. Furuhashi M, Hiramitsu S, Mita T, Fuseya T, Ishimura S, Omori A, Matsumoto M, Watanabe Y, Hoshina K, Tanaka M, Moniwa N, Yoshida H, Ishii J, Miura T, Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus. J Lipid Res 2015 56 2372 2380. doi: 10.1194/jlr.M059469
48. Furuhashi M, Hiramitsu S, Mita T, Omori A, Fuseya T, Ishimura S, Watanabe Y, Hoshina K, Matsumoto M, Tanaka M, Moniwa N, Yoshida H, Ishii J, Miura T, Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters. Lipids Health Dis 2016 15 5. doi: 10.1186/s12944-016-0177-8